Patents Assigned to PHOTOLITEC, LLC
  • Epidermal growth factor receptor (EGFR) targeted photosensitizers
    Patent number: 11083793
    Abstract: Compounds including a tetrapyrrolic or reduced tetrapyrrolic group/moiety and an epidermal growth factor receptor targeting group are disclosed. For example, a compound includes a tetrapyrrolic or reduced tetrapyrrolic group or moiety, a linker moiety, an epidermal growth factor receptor targeting group, and, optionally, a PET-active functional group. Uses of the compounds, for example, methods of treating a hyperproliferative tissue in an individual, and kits including one or more of the compounds are also provided.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: August 10, 2021
    Assignees: Health Research, Inc., Photolitec, LLC
    Inventors: Ravindra K. Pandey, Heinz Baumann, Khurshid Guru, Ravindra Cheruku, Erin Tracy, Farukh Durrani, Joseph Cacaccio, Kevin Siters
  • PAA nanoparticles for tumor treatment and imaging
    Patent number: 9045488
    Abstract: A tetrapyrrolic photosensitizer and imaging compound having a substituent other than hydrogen at its 10 carbon atom which substituent may contain a PAA nanoparticle.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: June 2, 2015
    Assignee: Photolitec, LLC
    Inventors: Ravindra K. Pandey, Anurag Gupta, Penny Joshi, Manivannan Ethirajan, Avinash Srivatsan
  • PAA NANOPARTICLES FOR TUMOR TREATMENT AND IMAGING
    Publication number: 20140011989
    Abstract: A tetrapyrrolic photosensitizer and imaging compound having a substituent other than hydrogen at its 10 carbon atom which substituent may contain a PAA nanoparticle.
    Type: Application
    Filed: July 9, 2012
    Publication date: January 9, 2014
    Applicant: PHOTOLITEC, LLC
    Inventors: Ravindra K. Pandey, Anurag Gupta, Penny Joshi, Manivannan Ethirajan, Avinash Srivatsan